Kyowa Kirin’s gene therapy most expensive US drug with $4.3 mln price tag
March 20 (Reuters) - Orchard Therapeutics, a unit of Japan's Kyowa Kirin , priced its newly approved gene therapy for a rare, life-threatening genetic disease on Wednesday at $4.25 million,…
